If side effects occur, the most common are nausea, indigestion, flatulence, diarrhea, constipation, headache, and fatigue, which usually resolves within the first month of use
An FH genetic panel was obtained by oral swab (Invitae) and returned as negative for mutations characteristic of this disease
However, there was limited clinical evidence comparing their impact on COPD outcomes in patients with type 2 diabetes. Researchers continue studying GLP-1 medications beyond diabetes and weight loss because they may have additional health benefits, such as reducing inflammation, improving lung function, and lowering the risk of conditions like COPD exacerbations, added Avik Ray, MD, MS, research fellow at the Division of Pharmacoepidemiology at Brigham and Womens Hospital and Harvard Medical School, first author of this study
The 4.5 mg dose reduced A1C by 1.9 percentage points, and led to an average weight loss of 10.4 pounds